CI
CorMedix Inc
🇩🇪XFRA.19KAGermanyHealthcare
€6.63EURdown -0.12 (-1.78%)OpenEnd of day6:55 PM
Price€6.63-0.12 (-1.78%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US21900C3088
- CUSIP
- Not reported
Company
- Employees
- 191
- Headquarters
- Parsippany, United States
- Website
- https://cormedix.com
- CEO
- Mr. Joseph Todisco MBA
Market
- Shares outstanding
- 78.8M
- Market cap
- €522.37M
Highlights
- Market cap
- €522.37M
- EPS LTM
- $2.02
- P/E LTM
- 3.86
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $462.25M+280.5%up year on year
- Net income
- $187.17M+265.86%up year on year
- Gross margin
- 82.78%-13.43%down year on year
- Free cash flow
- $251.71M+727.72%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.